-
1
-
-
84907041622
-
The electrophoretic alpha 1 globulin pattern of serum in alpha 1 antitrypsin deficiency
-
1:CAS:528:DyaF3sXksFOls7g%3D
-
Laurell CB, Eriksson S. The electrophoretic alpha 1 globulin pattern of serum in alpha 1 antitrypsin deficiency. Scand J Clin Lab Invest. 1963;15:132-40.
-
(1963)
Scand J Clin Lab Invest
, vol.15
, pp. 132-140
-
-
Laurell, C.B.1
Eriksson, S.2
-
2
-
-
0002203166
-
Studies in alpha 1 antitrypsin deficiency
-
Eriksson S. Studies in alpha 1 antitrypsin deficiency. Acta Med Scand. 1965;177(Suppl):432.
-
(1965)
Acta Med Scand
, vol.177
, Issue.SUPPL..
, pp. 432
-
-
Eriksson, S.1
-
3
-
-
0019978932
-
1-antitrypsin
-
DOI 10.1038/298329a0
-
Carrell RW, Jeppsson JO, Laurell CB, Brennan SO, Owen MC, Vaughan L, et al. Structure and variation of human alpha 1-antitrypsin. Nature. 1982;298(5872):329-34. (Pubitemid 12044284)
-
(1982)
Nature
, vol.298
, Issue.5872
, pp. 329-334
-
-
Carrell, R.W.1
Jeppsson, J.O.2
Laurell, C.B.3
-
4
-
-
0019369133
-
Emphysema induced in vitro and in vivo in dogs by a purified elastase from homologous leukocytes
-
Sloan B, Abrams WR, Meranze DR, Kimbel P, Weinbaum G. Emphysema induced in vitro and in vivo in dogs by a purified elastase from homologous leukocytes. Am Rev Respir Dis. 1981;124(3):295-301. (Pubitemid 11003995)
-
(1981)
American Review of Respiratory Disease
, vol.124
, Issue.3
, pp. 295-301
-
-
Sloan, B.1
Abrams, W.R.2
Meranze, D.R.3
-
5
-
-
0017669252
-
The induction of pulmonary emphysema with human leukocyte elastase
-
Senior RM, Tegner H, Kuhn C, Ohlsson K, Starcher BC, Pierce JA. The induction of pulmonary emphysema with human leukocyte elastase. Am Rev Respir Dis. 1977;116(3):469-75. (Pubitemid 8181304)
-
(1977)
American Review of Respiratory Disease
, vol.116
, Issue.3
, pp. 469-475
-
-
Senior, R.M.1
Tegner, H.2
Kuhn, C.3
-
6
-
-
0021337902
-
Emphysema and bronchial secretory cell metaplasia induced in hamsters by human neutrophil products
-
Snider GL, Lucey EC, Christensen TG, Stone PJ, Calore JD, Catanese A, et al. Emphysema and bronchial secretory cell metaplasia induced in hamsters by human neutrophil products. Am Rev Respir Dis. 1984;129(1):155-60. (Pubitemid 14176520)
-
(1984)
American Review of Respiratory Disease
, vol.129
, Issue.1
, pp. 155-160
-
-
Snider, G.L.1
Lucey, E.C.2
Christensen, T.G.3
-
7
-
-
0032717991
-
Neutrophils and protease/antiprotease imbalance
-
10556170 1:STN:280:DC%2BD3c%2FksFSiuw%3D%3D 10.1164/ajrccm.160. supplement-1.13
-
Stockley RA. Neutrophils and protease/antiprotease imbalance. Am J Respir Crit Care Med. 1999;160(5 Pt 2):S49-52.
-
(1999)
Am J Respir Crit Care Med
, vol.160
, Issue.5 PART 2
-
-
Stockley, R.A.1
-
8
-
-
0026755363
-
The mechanism of Z alpha 1-antitrypsin accumulation in the liver
-
1608473 1:CAS:528:DyaK38Xks1Oqu7w%3D 10.1038/357605a0
-
Lomas DA, Evans DL, Finch JT, Carrell RW. The mechanism of Z alpha 1-antitrypsin accumulation in the liver. Nature. 1992;357(6379):605-7.
-
(1992)
Nature
, vol.357
, Issue.6379
, pp. 605-607
-
-
Lomas, D.A.1
Evans, D.L.2
Finch, J.T.3
Carrell, R.W.4
-
9
-
-
34547647784
-
Alpha one antitrypsin deficiency: From gene to treatment
-
DOI 10.1159/000105536
-
Wood AM, Stockley RA. Alpha one antitrypsin deficiency: from gene to treatment. Respiration. 2007;74(5):481-92. (Pubitemid 47206875)
-
(2007)
Respiration
, vol.74
, Issue.5
, pp. 481-492
-
-
Wood, A.M.1
Stockley, R.A.2
-
10
-
-
77950179576
-
Genetic variants of alpha1-antitrypsin
-
19751191 1:CAS:528:DC%2BC3cXkt1eltr8%3D 10.2174/138920310790848368
-
Salahuddin P. Genetic variants of alpha1-antitrypsin. Curr Protein Pept Sci. 2010;11(2):101-17.
-
(2010)
Curr Protein Pept Sci
, vol.11
, Issue.2
, pp. 101-117
-
-
Salahuddin, P.1
-
12
-
-
0017099344
-
Liver disease in alpha1-antitrypsin deficiency detected by screening of 200,000 infants
-
1083485 1:STN:280:DyaE287nsVeltQ%3D%3D 10.1056/NEJM197606102942404
-
Sveger T. Liver disease in alpha1-antitrypsin deficiency detected by screening of 200,000 infants. N Engl J Med. 1976;294(24):1316-21.
-
(1976)
N Engl J Med
, vol.294
, Issue.24
, pp. 1316-1321
-
-
Sveger, T.1
-
13
-
-
0036014834
-
1-antitrypsin are chemotactic for human neutrophils: A new paradigm for the pathogenesis of emphysema
-
Parmar JS, Mahadeva R, Reed BJ, Farahi N, Cadwallader KA, Keogan MT, et al. Polymers of alpha(1)-antitrypsin are chemotactic for human neutrophils: a new paradigm for the pathogenesis of emphysema. Am J Respir Cell Mol Biol. 2002;26(6):723-30. (Pubitemid 34557374)
-
(2002)
American Journal of Respiratory Cell and Molecular Biology
, vol.26
, Issue.6
, pp. 723-730
-
-
Parmar, J.S.1
Mahadeva, R.2
Reed, B.J.3
Farahi, N.4
Cadwallader, K.A.5
Keogan, M.T.6
Bilton, D.7
Chilvers, E.R.8
Lomas, D.A.9
-
14
-
-
34248658381
-
α-1 antitrypsin inhibits caspase-3 activity, preventing lung endothelial cell apoptosis
-
DOI 10.2353/ajpath.2006.060058
-
Petrache I, Fijalkowska I, Medler TR, Skirball J, Cruz P, Zhen L, et al. Alpha-1 antitrypsin inhibits caspase-3 activity, preventing lung endothelial cell apoptosis. Am J Pathol. 2006;169(4):1155-66. (Pubitemid 351194353)
-
(2006)
American Journal of Pathology
, vol.169
, Issue.4
, pp. 1155-1166
-
-
Petrache, I.1
Fijalkowska, I.2
Medler, T.R.3
Skirball, J.4
Cruz, P.5
Zhen, L.6
Petrache, H.I.7
Flotte, T.R.8
Tuder, R.M.9
-
15
-
-
67651204310
-
Oxidized {alpha}1-antitrypsin stimulates the release of monocyte chemotactic protein-1 from lung epithelial cells: Potential role in emphysema
-
19525388 1:CAS:528:DC%2BD1MXhtVahtrrP 10.1152/ajplung.90373.2008
-
Li Z, Alam S, Wang J, Sandstrom CS, Janciauskiene S, Mahadeva R. Oxidized {alpha}1-antitrypsin stimulates the release of monocyte chemotactic protein-1 from lung epithelial cells: potential role in emphysema. Am J Physiol Lung Cell Mol Physiol. 2009;297(2):L388-400.
-
(2009)
Am J Physiol Lung Cell Mol Physiol
, vol.297
, Issue.2
-
-
Li, Z.1
Alam, S.2
Wang, J.3
Sandstrom, C.S.4
Janciauskiene, S.5
Mahadeva, R.6
-
16
-
-
37149030877
-
1- antitrypsin deficiency
-
DOI 10.1164/rccm.200703-489OC
-
Parr DG, Guest PG, Reynolds JH, Dowson LJ, Stockley RA. Prevalence and impact of bronchiectasis in alpha1-antitrypsin deficiency. Am J Respir Crit Care Med. 2007;176(12):1215-21. (Pubitemid 350256475)
-
(2007)
American Journal of Respiratory and Critical Care Medicine
, vol.176
, Issue.12
, pp. 1215-1221
-
-
Parr, D.G.1
Guest, P.G.2
Reynolds, J.H.3
Dowson, L.J.4
Stockley, R.A.5
-
17
-
-
80052478226
-
ANCA-associated vasculitis is linked to carriage of the Z allele of alpha(1) antitrypsin and its polymers
-
21821620 1:CAS:528:DC%2BC3MXhtl2rsr3N 10.1136/ard.2011.153569
-
Morris H, Morgan MD, Wood AM, Smith SW, Ekeowa UI, Herrmann K, et al. ANCA-associated vasculitis is linked to carriage of the Z allele of alpha(1) antitrypsin and its polymers. Ann Rheum Dis. 2011;70(10):1851-6.
-
(2011)
Ann Rheum Dis
, vol.70
, Issue.10
, pp. 1851-1856
-
-
Morris, H.1
Morgan, M.D.2
Wood, A.M.3
Smith, S.W.4
Ekeowa, U.I.5
Herrmann, K.6
-
18
-
-
2442621622
-
1-Antitrypsin deficiency·3: Clinical manifestations and natural history
-
DOI 10.1136/thx.2003.006510
-
Needham M, Stockley RA. Alpha 1-antitrypsin deficiency. 3: Clinical manifestations and natural history. Thorax. 2004;59(5):441-5. (Pubitemid 38624753)
-
(2004)
Thorax
, vol.59
, Issue.5
, pp. 441-445
-
-
Needham, M.1
Stockley, R.A.2
-
19
-
-
77955606635
-
Outdoor air pollution is associated with rapid decline of lung function in alpha-1-antitrypsin deficiency
-
20519748 1:CAS:528:DC%2BC3cXhtV2rtbnK 10.1136/oem.2009.047589
-
Wood AM, Harrison RM, Semple S, Ayres JG, Stockley RA. Outdoor air pollution is associated with rapid decline of lung function in alpha-1-antitrypsin deficiency. Occup Environ Med. 2010;67(8):556-61.
-
(2010)
Occup Environ Med
, vol.67
, Issue.8
, pp. 556-561
-
-
Wood, A.M.1
Harrison, R.M.2
Semple, S.3
Ayres, J.G.4
Stockley, R.A.5
-
20
-
-
52649167915
-
The TNFalpha gene relates to clinical phenotype in alpha-1-antitrypsin deficiency
-
18620570 10.1186/1465-9921-9-52 1:CAS:528:DC%2BD1cXhtFWgt7bK
-
Wood AM, Simmonds MJ, Bayley DL, Newby PR, Gough SC, Stockley RA. The TNFalpha gene relates to clinical phenotype in alpha-1-antitrypsin deficiency. Respir Res. 2008;9:52.
-
(2008)
Respir Res
, vol.9
, pp. 52
-
-
Wood, A.M.1
Simmonds, M.J.2
Bayley, D.L.3
Newby, P.R.4
Gough, S.C.5
Stockley, R.A.6
-
21
-
-
79951958144
-
Vitamin D-binding protein contributes to COPD by activation of alveolar macrophages
-
21228423 1:STN:280:DC%2BC3M3gtF2rsA%3D%3D 10.1136/thx.2010.140921
-
Wood AM, Bassford C, Webster D, Newby P, Rajesh P, Stockley RA, et al. Vitamin D-binding protein contributes to COPD by activation of alveolar macrophages. Thorax. 2011;66(3):205-10.
-
(2011)
Thorax
, vol.66
, Issue.3
, pp. 205-210
-
-
Wood, A.M.1
Bassford, C.2
Webster, D.3
Newby, P.4
Rajesh, P.5
Stockley, R.A.6
-
22
-
-
84857229152
-
Association of IREB2 and CHRNA3 polymorphisms with airflow obstruction in severe alpha-1 antitrypsin deficiency
-
22356581 1:CAS:528:DC%2BC38XlsVanu78%3D 10.1186/1465-9921-13-16
-
Kim WJ, Wood AM, Barker AF, Brantly ML, Campbell EJ, Eden E, et al. Association of IREB2 and CHRNA3 polymorphisms with airflow obstruction in severe alpha-1 antitrypsin deficiency. Respir Res. 2012;13:16.
-
(2012)
Respir Res
, vol.13
, pp. 16
-
-
Kim, W.J.1
Wood, A.M.2
Barker, A.F.3
Brantly, M.L.4
Campbell, E.J.5
Eden, E.6
-
23
-
-
27144471656
-
1-antitrypsin deficiency: A continuing problem
-
DOI 10.1378/chest.128.4.1989
-
Stoller JK, Sandhaus RA, Turino G, Dickson R, Rodgers K, Strange C. Delay in diagnosis of alpha1-antitrypsin deficiency: a continuing problem. Chest. 2005;128(4):1989-94. (Pubitemid 41507532)
-
(2005)
Chest
, vol.128
, Issue.4
, pp. 1989-1994
-
-
Stoller, J.K.1
Sandhaus, R.A.2
Turino, G.3
Dickson, R.4
Rodgers, K.5
Strange, C.6
-
24
-
-
84874708546
-
Age related development of respiratory abnormalities in non-index alpha-1 antitrypsin deficient studies
-
23276486 10.1016/j.rmed.2012.12.003
-
Holme J, Stockley JA, Stockley RA. Age related development of respiratory abnormalities in non-index alpha-1 antitrypsin deficient studies. Respir Med. 2013;107(3):387-93.
-
(2013)
Respir Med
, vol.107
, Issue.3
, pp. 387-393
-
-
Holme, J.1
Stockley, J.A.2
Stockley, R.A.3
-
25
-
-
0030446288
-
1- antitrypsin deficiency
-
Turino GM, Barker AF, Brantly ML, Cohen AB, Connelly RP, Crystal RG, et al. Clinical features of individuals with PISZ phenotype of alpha 1-antitrypsin deficiency. alpha 1-Antitrypsin Deficiency Registry Study Group. Am J Respir Crit Care Med. 1996;154(6 Pt 1):1718-25. (Pubitemid 26424941)
-
(1996)
American Journal of Respiratory and Critical Care Medicine
, vol.154
, Issue.6
, pp. 1718-1725
-
-
Turino, G.M.1
Barker, A.F.2
Brantly, M.L.3
Cohen, A.B.4
Connelly, R.P.5
Crystal, R.G.6
Eden, E.7
Schluchter, M.D.8
Stoller, J.K.9
-
26
-
-
0019787989
-
Replacement therapy of alpha 1-antitrypsin deficiency. Reversal of protease-antiprotease imbalance within the alveolar structures of PiZ subjects
-
Gadek JE, Klein HG, Holland PV, Crystal RG. Replacement therapy of alpha 1-antitrypsin deficiency. Reversal of protease-antiprotease imbalance within the alveolar structures of PiZ subjects. J Clin Investig. 1981;68(5):1158-65. (Pubitemid 12235015)
-
(1981)
Journal of Clinical Investigation
, vol.68
, Issue.5
, pp. 1158-1165
-
-
Gadek, J.E.1
Klein, H.G.2
Holland, P.V.3
Crystal, R.G.4
-
27
-
-
0023148995
-
1-antitrypsin deficiency associated with emphysema
-
Wewers MD, Casolaro MA, Sellers SE, Swayze SC, McPhaul KM, Wittes JT, et al. Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema. N Engl J Med. 1987;316(17):1055-62. (Pubitemid 17047294)
-
(1987)
New England Journal of Medicine
, vol.316
, Issue.17
, pp. 1055-1062
-
-
Wewers, M.D.1
Casolaro, M.A.2
Sellers, S.E.3
-
28
-
-
0141706635
-
American Thoracic Society/European Respiratory Society statement: Standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency
-
American Thoracic Society/European Respiratory Society
-
American Thoracic Society/European Respiratory Society. American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med. 2003;168(7):818-900.
-
(2003)
Am J Respir Crit Care Med
, vol.168
, Issue.7
, pp. 818-900
-
-
-
29
-
-
0031242842
-
1- antitrypsin deficiency?
-
DOI 10.1183/09031936.97.10102260
-
Seersholm N, Wencker M, Banik N, Viskum K, Dirksen A, Kok-Jensen A, et al. Does alpha1-antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha1-antitrypsin deficiency? Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL) alpha1-AT study group. Eur Respir J. 1997;10(10):2260-3. (Pubitemid 27479546)
-
(1997)
European Respiratory Journal
, vol.10
, Issue.10
, pp. 2260-2263
-
-
Seersholm, N.1
Wencker, M.2
Banik, N.3
Viskum, K.4
Dirksen, A.5
Kok-Jensen, A.6
Konietzko, N.7
-
30
-
-
0031884479
-
1-antitrypsin
-
DOI 10.1183/09031936.98.11020428
-
Wencker M, Banik N, Buhl R, Seidel R, Konietzko N. Long-term treatment of alpha1-antitrypsin deficiency-related pulmonary emphysema with human alpha1-antitrypsin. Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL)-alpha1-AT-study group. Eur Respir J. 1998;11(2):428-33. (Pubitemid 28108360)
-
(1998)
European Respiratory Journal
, vol.11
, Issue.2
, pp. 428-433
-
-
Wencker, M.1
Banik, N.2
Buhl, R.3
Seidel, R.4
Konietzko, N.5
-
31
-
-
84859354170
-
Reduction of severe exacerbations and hospitalization-derived costs in alpha-1-antitrypsin-deficient patients treated with alpha-1-antitrypsin augmentation therapy
-
22354900 1:CAS:528:DC%2BC38Xot1egtb0%3D 10.1177/1753465812438387
-
Barros-Tizon JC, Torres ML, Blanco I, Martinez MT. Reduction of severe exacerbations and hospitalization-derived costs in alpha-1-antitrypsin-deficient patients treated with alpha-1-antitrypsin augmentation therapy. Ther Adv Respir Dis. 2012;6(2):67-78.
-
(2012)
Ther Adv Respir Dis
, vol.6
, Issue.2
, pp. 67-78
-
-
Barros-Tizon, J.C.1
Torres, M.L.2
Blanco, I.3
Martinez, M.T.4
-
32
-
-
0032110436
-
Survival and FEV1 decline in individuals with severe deficiency of alpha1-antitrypsin
-
The Alpha-1-Antitrypsin Deficiency Registry Study Group
-
Survival and FEV1 decline in individuals with severe deficiency of alpha1-antitrypsin. The Alpha-1-Antitrypsin Deficiency Registry Study Group. Am J Respir Crit Care Med. 1998;158(1):49-59.
-
(1998)
Am J Respir Crit Care Med.
, vol.158
, Issue.1
, pp. 49-59
-
-
-
33
-
-
0032724157
-
A randomized clinical trial of alpha(1)-antitrypsin augmentation therapy
-
10556107 1:STN:280:DC%2BD3c%2FislKltg%3D%3D 10.1164/ajrccm.160.5.9901055
-
Dirksen A, Dijkman JH, Madsen F, Stoel B, Hutchison DC, Ulrik CS, et al. A randomized clinical trial of alpha(1)-antitrypsin augmentation therapy. Am J Respir Crit Care Med. 1999;160(5 Pt 1):1468-72.
-
(1999)
Am J Respir Crit Care Med
, vol.160
, Issue.5 PART 1
, pp. 1468-1472
-
-
Dirksen, A.1
Dijkman, J.H.2
Madsen, F.3
Stoel, B.4
Hutchison, D.C.5
Ulrik, C.S.6
-
34
-
-
67649407825
-
Exploring the role of CT densitometry: A randomised study of augmentation therapy in alpha1-antitrypsin deficiency
-
19196813 1:CAS:528:DC%2BD1MXoslyht70%3D 10.1183/09031936.00159408
-
Dirksen A, Piitulainen E, Parr DG, Deng C, Wencker M, Shaker SB, et al. Exploring the role of CT densitometry: a randomised study of augmentation therapy in alpha1-antitrypsin deficiency. Eur Respir J. 2009;33(6):1345-53.
-
(2009)
Eur Respir J
, vol.33
, Issue.6
, pp. 1345-1353
-
-
Dirksen, A.1
Piitulainen, E.2
Parr, D.G.3
Deng, C.4
Wencker, M.5
Shaker, S.B.6
-
35
-
-
77955487511
-
Intravenous alpha-1 antitrypsin augmentation therapy for treating patients with alpha-1 antitrypsin deficiency and lung disease
-
Epub 2010/07/09
-
Gotzsche PC, Johansen HK. Intravenous alpha-1 antitrypsin augmentation therapy for treating patients with alpha-1 antitrypsin deficiency and lung disease. Cochrane Database Syst Rev. 2010;(7):CD007851. Epub 2010/07/09.
-
(2010)
Cochrane Database Syst Rev.
, Issue.7
-
-
Gotzsche, P.C.1
Johansen, H.K.2
-
36
-
-
78649455530
-
Exploring the optimum approach to the use of CT densitometry in a randomised placebo-controlled study of augmentation therapy in alpha 1-antitrypsin deficiency
-
19678952 10.1186/1465-9921-10-75 1:CAS:528:DC%2BD1MXhtVemurfM
-
Parr DG, Dirksen A, Piitulainen E, Deng C, Wencker M, Stockley RA. Exploring the optimum approach to the use of CT densitometry in a randomised placebo-controlled study of augmentation therapy in alpha 1-antitrypsin deficiency. Respir Res. 2009;10:75.
-
(2009)
Respir Res
, vol.10
, pp. 75
-
-
Parr, D.G.1
Dirksen, A.2
Piitulainen, E.3
Deng, C.4
Wencker, M.5
Stockley, R.A.6
-
37
-
-
77957273246
-
Therapeutic efficacy of alpha-1 antitrypsin augmentation therapy on the loss of lung tissue: An integrated analysis of 2 randomised clinical trials using computed tomography densitometry
-
20920370 10.1186/1465-9921-11-136 1:CAS:528:DC%2BC3cXht1KlsLfO
-
Stockley RA, Parr DG, Piitulainen E, Stolk J, Stoel BC, Dirksen A. Therapeutic efficacy of alpha-1 antitrypsin augmentation therapy on the loss of lung tissue: an integrated analysis of 2 randomised clinical trials using computed tomography densitometry. Respir Res. 2010;11:136.
-
(2010)
Respir Res
, vol.11
, pp. 136
-
-
Stockley, R.A.1
Parr, D.G.2
Piitulainen, E.3
Stolk, J.4
Stoel, B.C.5
Dirksen, A.6
-
38
-
-
70350450961
-
Augmentation therapy for alpha1 antitrypsin deficiency: A meta-analysis
-
19811373 10.1080/15412550902905961
-
Chapman KR, Stockley RA, Dawkins C, Wilkes MM, Navickis RJ. Augmentation therapy for alpha1 antitrypsin deficiency: a meta-analysis. COPD. 2009;6(3):177-84.
-
(2009)
COPD
, vol.6
, Issue.3
, pp. 177-184
-
-
Chapman, K.R.1
Stockley, R.A.2
Dawkins, C.3
Wilkes, M.M.4
Navickis, R.J.5
-
39
-
-
0023784904
-
Biochemical efficacy and safety of monthly augmentation therapy for alpha 1-antitrypsin deficiency
-
3261353 1:STN:280:DyaL1czgtV2rtA%3D%3D 10.1001/jama.1988.03410090091037
-
Hubbard RC, Sellers S, Czerski D, Stephens L, Crystal RG. Biochemical efficacy and safety of monthly augmentation therapy for alpha 1-antitrypsin deficiency. JAMA. 1988;260(9):1259-64.
-
(1988)
JAMA
, vol.260
, Issue.9
, pp. 1259-1264
-
-
Hubbard, R.C.1
Sellers, S.2
Czerski, D.3
Stephens, L.4
Crystal, R.G.5
-
40
-
-
0038391385
-
1-antitrypsin
-
Piitulainen E, Bernspang E, Bjorkman S, Berntorp E. Tailored pharmacokinetic dosing allows self-administration and reduces the cost of IV augmentation therapy with human alpha(1)-antitrypsin. Eur J Clin Pharmacol. 2003;59(2):151-6. (Pubitemid 36793728)
-
(2003)
European Journal of Clinical Pharmacology
, vol.59
, Issue.2
, pp. 151-156
-
-
Piitulainen, E.1
Bernspang, E.2
Bjorkman, S.3
Berntorp, E.4
-
41
-
-
42949085601
-
1-antitrypsin deficiency: From pharmacokinetic analysis to individualizing therapy
-
DOI 10.1345/aph.1K505
-
Zamora NP, Pla RV, Del Rio PG, Margaleff RJ, Frias FR, Ronsano JB. Intravenous human plasma-derived augmentation therapy in alpha 1-antitrypsin deficiency: from pharmacokinetic analysis to individualizing therapy. Ann Pharmacother. 2008;42(5):640-6. (Pubitemid 351619934)
-
(2008)
Annals of Pharmacotherapy
, vol.42
, Issue.5
, pp. 640-646
-
-
Zamora, N.P.1
Pla, R.V.2
Del Rio, P.G.3
Margaleff, R.J.4
Frias, F.R.5
Ronsano, J.B.M.6
-
42
-
-
77957201481
-
Pharmacokinetic comparability of Prolastin(R)-C to Prolastin(R) in alpha(1)-antitrypsin deficiency: A randomized study
-
20920295 10.1186/1472-6904-10-13 1:CAS:528:DC%2BC3cXht1ygsbnI
-
Stocks JM, Brantly ML, Wang-Smith L, Campos MA, Chapman KR, Kueppers F, et al. Pharmacokinetic comparability of Prolastin(R)-C to Prolastin(R) in alpha(1)-antitrypsin deficiency: a randomized study. BMC Clin Pharmacol. 2010;10:13.
-
(2010)
BMC Clin Pharmacol
, vol.10
, pp. 13
-
-
Stocks, J.M.1
Brantly, M.L.2
Wang-Smith, L.3
Campos, M.A.4
Chapman, K.R.5
Kueppers, F.6
-
43
-
-
33845227581
-
Alpha-1-antitrypsin deficiency: Optimal therapeutic regimen based on population pharmacokinetics
-
DOI 10.1136/thx.2005.057943
-
Soy D, de la Roza C, Lara B, Esquinas C, Torres A, Miravitlles M. Alpha-1-antitrypsin deficiency: optimal therapeutic regimen based on population pharmacokinetics. Thorax. 2006;61(12):1059-64. (Pubitemid 44852024)
-
(2006)
Thorax
, vol.61
, Issue.12
, pp. 1059-1064
-
-
Soy, D.1
De La Roza, C.2
Lara, B.3
Esquinas, C.4
Torres, A.5
Miravitlles, M.6
-
44
-
-
84861316814
-
Alpha-1 antitrypsin deficiency targeted testing and augmentation therapy: A Canadian Thoracic Society clinical practice guideline
-
22536580
-
Marciniuk DD, Hernandez P, Balter M, Bourbeau J, Chapman KR, Ford GT, et al. Alpha-1 antitrypsin deficiency targeted testing and augmentation therapy: a Canadian Thoracic Society clinical practice guideline. Can Respir J. 2012;19(2):109-16.
-
(2012)
Can Respir J
, vol.19
, Issue.2
, pp. 109-116
-
-
Marciniuk, D.D.1
Hernandez, P.2
Balter, M.3
Bourbeau, J.4
Chapman, K.R.5
Ford, G.T.6
-
45
-
-
69249228595
-
Mortality in alpha-1-antitrypsin deficiency in the United Kingdom
-
19443188 10.1016/j.rmed.2009.04.004
-
Dawkins P, Wood A, Nightingale P, Stockley R. Mortality in alpha-1-antitrypsin deficiency in the United Kingdom. Respir Med. 2009;103(10):1540-7.
-
(2009)
Respir Med
, vol.103
, Issue.10
, pp. 1540-1547
-
-
Dawkins, P.1
Wood, A.2
Nightingale, P.3
Stockley, R.4
-
47
-
-
69249101657
-
Rate of progression of lung function impairment in alpha1-antitrypsin deficiency
-
19164359 1:STN:280:DC%2BD1MzosVWjsA%3D%3D 10.1183/09031936.00061208
-
Dawkins PA, Dawkins CL, Wood AM, Nightingale PG, Stockley JA, Stockley RA. Rate of progression of lung function impairment in alpha1-antitrypsin deficiency. Eur Respir J. 2009;33(6):1338-44.
-
(2009)
Eur Respir J
, vol.33
, Issue.6
, pp. 1338-1344
-
-
Dawkins, P.A.1
Dawkins, C.L.2
Wood, A.M.3
Nightingale, P.G.4
Stockley, J.A.5
Stockley, R.A.6
-
48
-
-
79953858686
-
Efficacy of alpha1-antitrypsin augmentation therapy in conditions other than pulmonary emphysema
-
21486454 10.1186/1750-1172-6-14
-
Blanco I, Lara B, de Serres F. Efficacy of alpha1-antitrypsin augmentation therapy in conditions other than pulmonary emphysema. Orphanet J Rare Dis. 2011;6:14.
-
(2011)
Orphanet J Rare Dis
, vol.6
, pp. 14
-
-
Blanco, I.1
Lara, B.2
De Serres, F.3
-
49
-
-
0025360692
-
1-antitrypsin deficiency by the aerosol route
-
Hubbard RC, Crystal RG. Strategies for aerosol therapy of alpha 1-antitrypsin deficiency by the aerosol route. Lung. 1990;168(Suppl):565-78. (Pubitemid 20217698)
-
(1990)
Lung
, vol.168
, Issue.SUPPL..
, pp. 565-578
-
-
Hubbard, R.C.1
Crystal, R.G.2
-
50
-
-
0034744066
-
1-protease inhibitor deficiency?
-
Kropp J, Wencker M, Hotze A, Banik N, Hubner GE, Wunderlich G, et al. Inhalation of [123I]alpha1-protease inhibitor: toward a new therapeutic concept of alpha1-protease inhibitor deficiency? J Nucl Med. 2001;42(5):744-51. (Pubitemid 32453463)
-
(2001)
Journal of Nuclear Medicine
, vol.42
, Issue.5
, pp. 744-751
-
-
Kropp, J.1
Wencker, M.2
Hotze, A.3
Banik, N.4
Hubner, G.E.5
Wunderlich, G.6
Ulbrich, E.7
Konietzko, N.8
Biersack, H.J.9
-
51
-
-
0042026773
-
1-protease inhibitor using commercial inhalation devices
-
DOI 10.1183/09031936.03.00096802
-
Brand P, Beckmann H, Maas Enriquez M, Meyer T, Mullinger B, Sommerer K, et al. Peripheral deposition of alpha1-protease inhibitor using commercial inhalation devices. Eur Respir J. 2003;22(2):263-7. (Pubitemid 36986995)
-
(2003)
European Respiratory Journal
, vol.22
, Issue.2
, pp. 263-267
-
-
Brand, P.1
Maas Enriquez, M.2
Meyer, T.3
Mllinger, B.4
Sommerer, K.5
Weber, N.6
Weuthen, T.7
Scheuch, G.8
-
52
-
-
69249120315
-
Lung deposition of inhaled alpha1-proteinase inhibitor in cystic fibrosis and alpha1-antitrypsin deficiency
-
19251783 1:CAS:528:DC%2BD1MXhtVCht77J 10.1183/09031936.00118408
-
Brand P, Schulte M, Wencker M, Herpich CH, Klein G, Hanna K, et al. Lung deposition of inhaled alpha1-proteinase inhibitor in cystic fibrosis and alpha1-antitrypsin deficiency. Eur Respir J. 2009;34(2):354-60.
-
(2009)
Eur Respir J
, vol.34
, Issue.2
, pp. 354-360
-
-
Brand, P.1
Schulte, M.2
Wencker, M.3
Herpich, C.H.4
Klein, G.5
Hanna, K.6
-
53
-
-
21244492343
-
A pilot study comparing the purity, functionality and isoform composition of alpha-1-proteinase inhibitor (human) products
-
DOI 10.1185/030079905X46395, 3011
-
Cowden DI, Fisher GE, Weeks RL. A pilot study comparing the purity, functionality and isoform composition of alpha-1-proteinase inhibitor (human) products. Curr Med Res Opin. 2005;21(6):877-83. (Pubitemid 40896236)
-
(2005)
Current Medical Research and Opinion
, vol.21
, Issue.6
, pp. 877-883
-
-
Cowden, D.I.1
Fisher, G.E.2
Weeks, R.L.3
-
54
-
-
33745065087
-
Recombinant human alpha-1 proteinase inhibitor: Towards therapeutic use
-
DOI 10.1007/s00726-005-0324-4
-
Karnaukhova E, Ophir Y, Golding B. Recombinant human alpha-1 proteinase inhibitor: towards therapeutic use. Amino Acids. 2006;30(4):317-32. (Pubitemid 43886895)
-
(2006)
Amino Acids
, vol.30
, Issue.4
, pp. 317-332
-
-
Karnaukhova, E.1
Ophir, Y.2
Golding, B.3
-
55
-
-
0036891151
-
232 prolongs the half-life of α1 Proteinase inhibitor
-
Cantin AM, Woods DE, Cloutier D, Dufour EK, Leduc R. Polyethylene glycol conjugation at Cys232 prolongs the half-life of alpha1 proteinase inhibitor. Am J Respir Cell Mol Biol. 2002;27(6):659-65. (Pubitemid 35381174)
-
(2002)
American Journal of Respiratory Cell and Molecular Biology
, vol.27
, Issue.6
, pp. 659-665
-
-
Cantin, A.M.1
Woods, D.E.2
Cloutier, D.3
Dufour, E.K.4
Leduc, R.5
-
56
-
-
0002175173
-
Cell surface carbohydrates: Cell type-specific expression
-
M. Fukada O. Hinghaul (eds) Oxford University Press New York
-
Fukada M. Cell surface carbohydrates: cell type-specific expression. In: Fukada M, Hinghaul O, editors. Molecular and cellular glycobiology. New York: Oxford University Press; 2000. p. 12-61.
-
(2000)
Molecular and Cellular Glycobiology
, pp. 12-61
-
-
Fukada, M.1
-
57
-
-
0036274761
-
1-proteinase inhibitor and improved anti-elastase activity of the inhibitor with glutamate at position 351
-
Sandoval C, Curtis H, Congote LF. Enhanced proliferative effects of a baculovirus-produced fusion protein of insulin-like growth factor and alpha(1)-proteinase inhibitor and improved anti-elastase activity of the inhibitor with glutamate at position 351. Protein Eng. 2002;15(5):413-8. (Pubitemid 34601733)
-
(2002)
Protein Engineering
, vol.15
, Issue.5
, pp. 413-418
-
-
Sandoval, C.1
Curtis, H.2
Congote, L.F.3
-
58
-
-
0027521818
-
Transgenic livestock as bioreactors: Stable expression of human alpha-1-antitrypsin by a flock of sheep
-
1:CAS:528:DyaK2cXnsFGitQ%3D%3D 10.1038/nbt1193-1263
-
Carver AS, Dalrymple MA, Wright G, Cottom DS, Reeves DB, Gibson YH, et al. Transgenic livestock as bioreactors: stable expression of human alpha-1-antitrypsin by a flock of sheep. Biotechnology (N Y). 1993;11(11):1263-70.
-
(1993)
Biotechnology (N Y)
, vol.11
, Issue.11
, pp. 1263-1270
-
-
Carver, A.S.1
Dalrymple, M.A.2
Wright, G.3
Cottom, D.S.4
Reeves, D.B.5
Gibson, Y.H.6
-
59
-
-
14744276106
-
High level expression of active human alpha-1-antitrypsin in the milk of transgenic sheep
-
1:CAS:528:DyaK38Xht1aitLk%3D 10.1038/nbt0991-830
-
Wright G, Carver A, Cottom D, Reeves D, Scott A, Simons P, et al. High level expression of active human alpha-1-antitrypsin in the milk of transgenic sheep. Biotechnology (N Y). 1991;9(9):830-4.
-
(1991)
Biotechnology (N Y)
, vol.9
, Issue.9
, pp. 830-834
-
-
Wright, G.1
Carver, A.2
Cottom, D.3
Reeves, D.4
Scott, A.5
Simons, P.6
-
61
-
-
0025285392
-
1- antitrypsin in the milk of transgenic mice
-
DOI 10.1073/pnas.87.13.5178
-
Archibald AL, McClenaghan M, Hornsey V, Simons JP, Clark AJ. High-level expression of biologically active human alpha 1-antitrypsin in the milk of transgenic mice. Proc Natl Acad Sci USA. 1990;87(13):5178-82. (Pubitemid 20224296)
-
(1990)
Proceedings of the National Academy of Sciences of the United States of America
, vol.87
, Issue.13
, pp. 5178-5182
-
-
Archibald, A.L.1
McClenaghan, M.2
Hornsey, V.3
Simons, J.P.4
Clark, A.J.5
-
62
-
-
0026725682
-
A 17.6 kbp region located upstream of the rabbit WAP gene directs high level expression of a functional human protein variant in transgenic mouse milk
-
1299629 1:CAS:528:DyaK38XltVGgtLs%3D 10.1016/0014-5793(92)80683-8
-
Bischoff R, Degryse E, Perraud F, Dalemans W, Ali-Hadji D, Thepot D, et al. A 17.6 kbp region located upstream of the rabbit WAP gene directs high level expression of a functional human protein variant in transgenic mouse milk. FEBS Lett. 1992;305(3):265-8.
-
(1992)
FEBS Lett
, vol.305
, Issue.3
, pp. 265-268
-
-
Bischoff, R.1
Degryse, E.2
Perraud, F.3
Dalemans, W.4
Ali-Hadji, D.5
Thepot, D.6
-
63
-
-
0036645686
-
1-antitrypsin into mouse urine
-
DOI 10.1042/BJ20020643
-
Zbikowska HM, Soukhareva N, Behnam R, Lubon H, Hammond D, Soukharev S. Uromodulin promoter directs high-level expression of biologically active human alpha1-antitrypsin into mouse urine. Biochem J. 2002;365(Pt 1):7-11. (Pubitemid 34756134)
-
(2002)
Biochemical Journal
, vol.365
, Issue.1
, pp. 7-11
-
-
Zbikowska, H.M.1
Soukhareva, N.2
Behnam, R.3
Lubon, H.4
Hammond, D.5
Soukharev, S.6
-
64
-
-
0025732278
-
Expression of active recombinant human alpha 1-antitrypsin in transgenic rabbits
-
1367260 1:CAS:528:DyaK3MXkt1els78%3D 10.1016/0168-1656(91)90247-S
-
Massoud M, Bischoff R, Dalemans W, Pointu H, Attal J, Schultz H, et al. Expression of active recombinant human alpha 1-antitrypsin in transgenic rabbits. J Biotechnol. 1991;18(3):193-203.
-
(1991)
J Biotechnol
, vol.18
, Issue.3
, pp. 193-203
-
-
Massoud, M.1
Bischoff, R.2
Dalemans, W.3
Pointu, H.4
Attal, J.5
Schultz, H.6
-
65
-
-
0030032878
-
Low levels of chimerism in rabbit fetuses produced from preimplantation embryos microinjected with fetal gonadal cells
-
DOI 10.1002/(SICI)1098-2795(199601) 43:1<38::AID-MRD5>3.0.CO;2-V
-
Moens A, Betteridge KJ, Brunet A, Renard JP. Low levels of chimerism in rabbit fetuses produced from preimplantation embryos microinjected with fetal gonadal cells. Mol Reprod Dev. 1996;43(1):38-46. (Pubitemid 26021945)
-
(1996)
Molecular Reproduction and Development
, vol.43
, Issue.1
, pp. 38-46
-
-
Moens, A.1
Betteridge, K.J.2
Brunet, A.3
Renard, J.-P.4
-
66
-
-
0141460564
-
Fertility and germline transmission of donor haplotype following germ cell transplantation in immunocompetent goats
-
DOI 10.1095/biolreprod.103.018788
-
Honaramooz A, Behboodi E, Megee SO, Overton SA, Galantino-Homer H, Echelard Y, et al. Fertility and germline transmission of donor haplotype following germ cell transplantation in immunocompetent goats. Biol Reprod. 2003;69(4):1260-4. (Pubitemid 37173860)
-
(2003)
Biology of Reproduction
, vol.69
, Issue.4
, pp. 1260-1264
-
-
Honaramooz, A.1
Behboodi, E.2
Megee, S.O.3
Overton, S.A.4
Galantino-Homer, H.5
Echelard, Y.6
Dobrinski, I.7
-
67
-
-
67049137904
-
First US approval for a transgenic animal drug
-
19352350 1:CAS:528:DC%2BD1MXktFaksLo%3D 10.1038/nbt0409-302
-
Kling J. First US approval for a transgenic animal drug. Nat Biotechnol. 2009;27(4):302-4.
-
(2009)
Nat Biotechnol
, vol.27
, Issue.4
, pp. 302-304
-
-
Kling, J.1
-
68
-
-
0017808477
-
1-anti-trypsin in rat circulation
-
DOI 10.1016/0020-711X(78)90020-4
-
Yu SD, Gan JC. Effects of progressive desialylation on the survival of human plasma alpha1-anti-trypsin in rat circulation. Int J Biochem. 1978;9(2):107-15. (Pubitemid 8301974)
-
(1978)
International Journal of Biochemistry
, vol.9
, Issue.2
, pp. 107-115
-
-
Yu, S.D.1
Gan, J.C.2
-
69
-
-
84868502136
-
Production and characterization of a novel human recombinant alpha-1-antitrypsin in PER.C6 cells
-
23036927 1:CAS:528:DC%2BC38Xhslejtb3L 10.1016/j.jbiotec.2012.09.018
-
Ross D, Brown T, Harper R, Pamarthi M, Nixon J, Bromirski J, et al. Production and characterization of a novel human recombinant alpha-1-antitrypsin in PER.C6 cells. J Biotechnol. 2012;162(2-3):262-73.
-
(2012)
J Biotechnol
, vol.162
, Issue.2-3
, pp. 262-273
-
-
Ross, D.1
Brown, T.2
Harper, R.3
Pamarthi, M.4
Nixon, J.5
Bromirski, J.6
-
70
-
-
84875384860
-
Structural characterization of recombinant alpha-1-antitrypsin expressed in a human cell line
-
Epub 2013/03/07
-
Wang Z, Hilder TL, Drift KV, Sloan J, Wee K. Structural characterization of recombinant alpha-1-antitrypsin expressed in a human cell line. Anal Biochem. 2013. Epub 2013/03/07.
-
(2013)
Anal Biochem
-
-
Wang, Z.1
Hilder, T.L.2
Drift, K.V.3
Sloan, J.4
Wee, K.5
-
71
-
-
0029048542
-
The Z type variation of human alpha 1-antitrypsin causes a protein folding defect
-
7664092 1:CAS:528:DyaK2MXlsFKltr8%3D 10.1038/nsb0595-363
-
Yu MH, Lee KN, Kim J. The Z type variation of human alpha 1-antitrypsin causes a protein folding defect. Nat Struct Biol. 1995;2(5):363-7.
-
(1995)
Nat Struct Biol
, vol.2
, Issue.5
, pp. 363-367
-
-
Yu, M.H.1
Lee, K.N.2
Kim, J.3
-
72
-
-
80051635385
-
Oxidation of Z alpha1-antitrypsin by cigarette smoke induces polymerization: A novel mechanism of early-onset emphysema
-
20971880 1:CAS:528:DC%2BC3MXhtVSitrrL 10.1165/rcmb.2010-0328OC
-
Alam S, Li Z, Janciauskiene S, Mahadeva R. Oxidation of Z alpha1-antitrypsin by cigarette smoke induces polymerization: a novel mechanism of early-onset emphysema. Am J Respir Cell Mol Biol. 2011;45(2):261-9.
-
(2011)
Am J Respir Cell Mol Biol
, vol.45
, Issue.2
, pp. 261-269
-
-
Alam, S.1
Li, Z.2
Janciauskiene, S.3
Mahadeva, R.4
-
73
-
-
0034652248
-
Chemical chaperones mediate increased secretion of mutant α1- antitrypsin (α1-AT) Z: A potential pharmacological strategy for prevention of liver injury and emphysema in α1-AT deficiency
-
DOI 10.1073/pnas.97.4.1796
-
Burrows JA, Willis LK, Perlmutter DH. Chemical chaperones mediate increased secretion of mutant alpha 1-antitrypsin (alpha 1-AT) Z: a potential pharmacological strategy for prevention of liver injury and emphysema in alpha 1-AT deficiency. Proc Natl Acad Sci USA. 2000;97(4):1796-801. (Pubitemid 30118522)
-
(2000)
Proceedings of the National Academy of Sciences of the United States of America
, vol.97
, Issue.4
, pp. 1796-1801
-
-
Burrows, J.A.J.1
Willis, L.K.2
Perlmutter, D.H.3
-
74
-
-
0034969249
-
1-AT deficiency
-
Devlin GL, Parfrey H, Tew DJ, Lomas DA, Bottomley SP. Prevention of polymerization of M and Z alpha1-Antitrypsin (alpha1-AT) with trimethylamine N-oxide. Implications for the treatment of alpha1-at deficiency. Am J Respir Cell Mol Biol. 2001;24(6):727-32. (Pubitemid 32550595)
-
(2001)
American Journal of Respiratory Cell and Molecular Biology
, vol.24
, Issue.6
, pp. 727-732
-
-
Devlin, G.L.1
Parfrey, H.2
Tew, D.J.3
Lomas, D.A.4
Bottomley, S.P.5
-
76
-
-
33750725161
-
1-antitrypsin
-
DOI 10.1165/rcmb.2005-0207OC
-
Chang YP, Mahadeva R, Chang WS, Shukla A, Dafforn TR, Chu YH. Identification of a 4-mer peptide inhibitor that effectively blocks the polymerization of pathogenic Z alpha1-antitrypsin. Am J Respir Cell Mol Biol. 2006;35(5):540-8. (Pubitemid 44706426)
-
(2006)
American Journal of Respiratory Cell and Molecular Biology
, vol.35
, Issue.5
, pp. 540-548
-
-
Chang, Y.-P.1
Mahadeva, R.2
Chang, W.-S.W.3
Shukla, A.4
Dafforn, T.R.5
Chu, Y.-H.6
-
77
-
-
0036510604
-
1-antitrypsin-related cirrhosis
-
DOI 10.1074/jbc.C100722200
-
Mahadeva R, Dafforn TR, Carrell RW, Lomas DA. 6-mer peptide selectively anneals to a pathogenic serpin conformation and blocks polymerization. Implications for the prevention of Z alpha(1)-antitrypsin-related cirrhosis. J Biol Chem. 2002;277(9):6771-4. (Pubitemid 34953057)
-
(2002)
Journal of Biological Chemistry
, vol.277
, Issue.9
, pp. 6771-6774
-
-
Mahadeva, R.1
Dafforn, T.R.2
Carrell, R.W.3
Lomas, D.A.4
-
78
-
-
4143133190
-
1-antitrypsin-related emphysema
-
DOI 10.1165/rcmb.2003-0276OC
-
Parfrey H, Dafforn TR, Belorgey D, Lomas DA, Mahadeva R. Inhibiting polymerization: new therapeutic strategies for Z alpha1-antitrypsin-related emphysema. Am J Respir Cell Mol Biol. 2004;31(2):133-9. (Pubitemid 39095442)
-
(2004)
American Journal of Respiratory Cell and Molecular Biology
, vol.31
, Issue.2
, pp. 133-139
-
-
Parfrey, H.1
Dafforn, T.R.2
Belorgey, D.3
Lomas, D.A.4
Mahadeva, R.5
-
79
-
-
35848929750
-
1- antitrypsin and increase the clearance of intracellular aggregates
-
DOI 10.1021/jm070687z
-
Mallya M, Phillips RL, Saldanha SA, Gooptu B, Brown SC, Termine DJ, et al. Small molecules block the polymerization of Z alpha1-antitrypsin and increase the clearance of intracellular aggregates. J Med Chem. 2007;50(22):5357-63. (Pubitemid 350057847)
-
(2007)
Journal of Medicinal Chemistry
, vol.50
, Issue.22
, pp. 5357-5363
-
-
Mallya, M.1
Phillips, R.L.2
Saldanha, S.A.3
Gooptu, B.4
Leigh Brown, S.C.5
Termine, D.J.6
Shirvani, A.M.7
Wu, Y.8
Sifers, R.N.9
Abagyan, R.10
Lomas, D.A.11
-
80
-
-
84862660301
-
Preventing and reversing the cellular consequences of Z alpha-1 antitrypsin accumulation by targeting s4A
-
22425623 1:CAS:528:DC%2BC38XovV2guro%3D 10.1016/j.jhep.2012.02.025
-
Alam S, Wang J, Janciauskiene S, Mahadeva R. Preventing and reversing the cellular consequences of Z alpha-1 antitrypsin accumulation by targeting s4A. J Hepatol. 2012;57(1):116-24.
-
(2012)
J Hepatol
, vol.57
, Issue.1
, pp. 116-124
-
-
Alam, S.1
Wang, J.2
Janciauskiene, S.3
Mahadeva, R.4
-
81
-
-
84868611206
-
The emerging importance of autophagy in pulmonary diseases
-
23131937 1:CAS:528:DC%2BC3sXnslCl 10.1378/chest.12-0809
-
Mizumura K, Cloonan SM, Haspel JA, Choi AM. The emerging importance of autophagy in pulmonary diseases. Chest. 2012;142(5):1289-99.
-
(2012)
Chest
, vol.142
, Issue.5
, pp. 1289-1299
-
-
Mizumura, K.1
Cloonan, S.M.2
Haspel, J.A.3
Choi, A.M.4
-
82
-
-
77954597127
-
An autophagy-enhancing drug promotes degradation of mutant alpha1-antitrypsin Z and reduces hepatic fibrosis
-
20522742 1:CAS:528:DC%2BC3cXosVWgu70%3D 10.1126/science.1190354
-
Hidvegi T, Ewing M, Hale P, Dippold C, Beckett C, Kemp C, et al. An autophagy-enhancing drug promotes degradation of mutant alpha1-antitrypsin Z and reduces hepatic fibrosis. Science. 2010;329(5988):229-32.
-
(2010)
Science
, vol.329
, Issue.5988
, pp. 229-232
-
-
Hidvegi, T.1
Ewing, M.2
Hale, P.3
Dippold, C.4
Beckett, C.5
Kemp, C.6
-
83
-
-
0026586140
-
Expression of human alpha 1-antitrypsin in dogs after autologous transplantation of retroviral transduced hepatocytes
-
1729724 1:CAS:528:DyaK38Xns1egtA%3D%3D 10.1073/pnas.89.1.89
-
Kay MA, Baley P, Rothenberg S, Leland F, Fleming L, Ponder KP, et al. Expression of human alpha 1-antitrypsin in dogs after autologous transplantation of retroviral transduced hepatocytes. Proc Natl Acad Sci USA. 1992;89(1):89-93.
-
(1992)
Proc Natl Acad Sci USA
, vol.89
, Issue.1
, pp. 89-93
-
-
Kay, M.A.1
Baley, P.2
Rothenberg, S.3
Leland, F.4
Fleming, L.5
Ponder, K.P.6
-
84
-
-
0026906987
-
Adenovirus-mediated in vivo gene transfer and expression in normal rat liver
-
1302034 1:CAS:528:DyaK38Xls1Gjs78%3D 10.1038/ng0892-372
-
Jaffe HA, Danel C, Longenecker G, Metzger M, Setoguchi Y, Rosenfeld MA, et al. Adenovirus-mediated in vivo gene transfer and expression in normal rat liver. Nat Genet. 1992;1(5):372-8.
-
(1992)
Nat Genet
, vol.1
, Issue.5
, pp. 372-378
-
-
Jaffe, H.A.1
Danel, C.2
Longenecker, G.3
Metzger, M.4
Setoguchi, Y.5
Rosenfeld, M.A.6
-
85
-
-
0025848772
-
Adenovirus-mediated transfer of a recombinant α1-antitrypsin gene to the lung epithelium in vivo
-
Rosenfeld MA, Siegfried W, Yoshimura K, Yoneyama K, Fukayama M, Stier LE, et al. Adenovirus-mediated transfer of a recombinant alpha 1-antitrypsin gene to the lung epithelium in vivo. Science. 1991;252(5004):431-4. (Pubitemid 21916979)
-
(1991)
Science
, vol.252
, Issue.5004
, pp. 431-434
-
-
Rosenfeld, M.A.1
Siegfried, W.2
Yoshimura, K.3
Yoneyama, K.4
Fukayama, M.5
Stier, L.E.6
Paakko, P.K.7
Gilardi, P.8
Stratford-Perricaudet, L.D.9
Perricaudet, M.10
Jallat, S.11
Pavirani, A.12
Lecocq, J.-P.13
Crystal, R.G.14
-
86
-
-
0032506791
-
1-antitrypsin with negligible toxicity
-
Morral N, Parks RJ, Zhou H, Langston C, Schiedner G, Quinones J, et al. High doses of a helper-dependent adenoviral vector yield supraphysiological levels of alpha1-antitrypsin with negligible toxicity. Hum Gene Ther. 1998;9(18):2709-16. (Pubitemid 29027014)
-
(1998)
Human Gene Therapy
, vol.9
, Issue.18
, pp. 2709-2716
-
-
Morral, N.1
Parks, R.J.2
Zhou, H.3
Langston, C.4
Schiedner, G.5
Quinones, J.6
Graham, F.L.7
Kochanek, S.8
Beaudet, A.L.9
-
87
-
-
0031916435
-
Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity
-
DOI 10.1038/ng0298-180
-
Schiedner G, Morral N, Parks RJ, Wu Y, Koopmans SC, Langston C, et al. Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity. Nat Genet. 1998;18(2):180-3. (Pubitemid 28082470)
-
(1998)
Nature Genetics
, vol.18
, Issue.2
, pp. 180-183
-
-
Schiedner, G.1
Morral, N.2
Parks, R.J.3
Wu, Y.4
Koopmans, S.C.5
Langston, C.6
Graham, F.L.7
Beaudet, A.L.8
Kochanek, S.9
-
88
-
-
0028899573
-
Therapeutic serum concentrations of human alpha-1-antitrypsin after adenoviral-mediated gene transfer into mouse hepatocytes
-
7875680 1:CAS:528:DyaK2MXltlentL0%3D
-
Kay MA, Graham F, Leland F, Woo SL. Therapeutic serum concentrations of human alpha-1-antitrypsin after adenoviral-mediated gene transfer into mouse hepatocytes. Hepatology. 1995;21(3):815-9.
-
(1995)
Hepatology
, vol.21
, Issue.3
, pp. 815-819
-
-
Kay, M.A.1
Graham, F.2
Leland, F.3
Woo, S.L.4
-
89
-
-
33745241652
-
Therapeutic level of functional human alpha 1 antitrypsin (hAAT) secreted from murine muscle transduced by adeno-associated virus (rAAV1) vector
-
16518879 1:CAS:528:DC%2BD28XnsVWjuro%3D 10.1002/jgm.896
-
Lu Y, Choi YK, Campbell-Thompson M, Li C, Tang Q, Crawford JM, et al. Therapeutic level of functional human alpha 1 antitrypsin (hAAT) secreted from murine muscle transduced by adeno-associated virus (rAAV1) vector. J Gene Med. 2006;8(6):730-5.
-
(2006)
J Gene Med
, vol.8
, Issue.6
, pp. 730-735
-
-
Lu, Y.1
Choi, Y.K.2
Campbell-Thompson, M.3
Li, C.4
Tang, Q.5
Crawford, J.M.6
-
90
-
-
0034828903
-
Stable therapeutic serum levels of human alpha-1 antitrypsin (AAT) after portal vein injection of recombinant adeno-associated virus (rAAV) vectors
-
DOI 10.1038/sj.gt.3301422
-
Song S, Embury J, Laipis PJ, Berns KI, Crawford JM, Flotte TR. Stable therapeutic serum levels of human alpha-1 antitrypsin (AAT) after portal vein injection of recombinant adeno-associated virus (rAAV) vectors. Gene Ther. 2001;8(17):1299-306. (Pubitemid 32834298)
-
(2001)
Gene Therapy
, vol.8
, Issue.17
, pp. 1299-1306
-
-
Song, S.1
Embury, J.2
Laipis, P.J.3
Berns, K.I.4
Crawford, J.M.5
Flotte, T.R.6
-
91
-
-
13144305062
-
Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors
-
DOI 10.1073/pnas.95.24.14384
-
Song S, Morgan M, Ellis T, Poirier A, Chesnut K, Wang J, et al. Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors. Proc Natl Acad Sci USA. 1998;95(24):14384-8. (Pubitemid 28549376)
-
(1998)
Proceedings of the National Academy of Sciences of the United States of America
, vol.95
, Issue.24
, pp. 14384-14388
-
-
Song, S.1
Morgan, M.2
Ellis, T.3
Poirier, A.4
Chesnut, K.5
Wang, J.6
Brantly, M.7
Muzyczka, N.8
Byrne, B.J.9
Atkinson, M.10
Flotte, T.R.11
-
92
-
-
0028172344
-
Expression of human alpha 1-antitrypsin in mouse after in vivo gene transfer to hepatocytes by small liposomes
-
7980573 1:CAS:528:DyaK2MXitV2gtr4%3D 10.1006/bbrc.1994.2565
-
Alino SF, Crespo J, Bobadilla M, Lejarreta M, Blaya C, Crespo A. Expression of human alpha 1-antitrypsin in mouse after in vivo gene transfer to hepatocytes by small liposomes. Biochem Biophys Res Commun. 1994;204(3):1023-30.
-
(1994)
Biochem Biophys Res Commun
, vol.204
, Issue.3
, pp. 1023-1030
-
-
Alino, S.F.1
Crespo, J.2
Bobadilla, M.3
Lejarreta, M.4
Blaya, C.5
Crespo, A.6
-
93
-
-
0028056371
-
Aerosol and intravenous transfection of human alpha 1-antitrypsin gene to lungs of rabbits
-
8292378 1:CAS:528:DyaK2cXlslWls7g%3D 10.1165/ajrcmb.10.1.8292378
-
Canonico AE, Conary JT, Meyrick BO, Brigham KL. Aerosol and intravenous transfection of human alpha 1-antitrypsin gene to lungs of rabbits. Am J Respir Cell Mol Biol. 1994;10(1):24-9.
-
(1994)
Am J Respir Cell Mol Biol
, vol.10
, Issue.1
, pp. 24-29
-
-
Canonico, A.E.1
Conary, J.T.2
Meyrick, B.O.3
Brigham, K.L.4
-
94
-
-
33845807816
-
1-antitrypsin (AAT) vector in AAT-deficient adults
-
DOI 10.1089/hum.2006.17.1177
-
Brantly ML, Spencer LT, Humphries M, Conlon TJ, Spencer CT, Poirier A, et al. Phase I trial of intramuscular injection of a recombinant adeno-associated virus serotype 2 alphal-antitrypsin (AAT) vector in AAT-deficient adults. Hum Gene Ther. 2006;17(12):1177-86. (Pubitemid 44975135)
-
(2006)
Human Gene Therapy
, vol.17
, Issue.12
, pp. 1177-1186
-
-
Brantly, M.L.1
Spencer, L.T.2
Humphries, M.3
Conlon, T.J.4
Spencer, C.T.5
Poirier, A.6
Garlington, W.7
Baker, D.8
Song, S.9
Berns, K.I.10
Muzyczka, N.11
Snyder, R.O.12
Byrne, B.J.13
Flotte, T.R.14
-
95
-
-
70349481529
-
Sustained transgene expression despite T lymphocyte responses in a clinical trial of rAAV1-AAT gene therapy
-
19706466 1:CAS:528:DC%2BD1MXht1Kqu7rO 10.1073/pnas.0904514106
-
Brantly ML, Chulay JD, Wang L, Mueller C, Humphries M, Spencer LT, et al. Sustained transgene expression despite T lymphocyte responses in a clinical trial of rAAV1-AAT gene therapy. Proc Natl Acad Sci USA. 2009;106(38):16363-8.
-
(2009)
Proc Natl Acad Sci USA
, vol.106
, Issue.38
, pp. 16363-16368
-
-
Brantly, M.L.1
Chulay, J.D.2
Wang, L.3
Mueller, C.4
Humphries, M.5
Spencer, L.T.6
-
96
-
-
80155145248
-
Phase 2 clinical trial of a recombinant adeno-associated viral vector expressing alpha1-antitrypsin: Interim results
-
21609134 1:CAS:528:DC%2BC3MXhsVSitbnN 10.1089/hum.2011.053
-
Flotte TR, Trapnell BC, Humphries M, Carey B, Calcedo R, Rouhani F, et al. Phase 2 clinical trial of a recombinant adeno-associated viral vector expressing alpha1-antitrypsin: interim results. Hum Gene Ther. 2011;22(10):1239-47.
-
(2011)
Hum Gene Ther
, vol.22
, Issue.10
, pp. 1239-1247
-
-
Flotte, T.R.1
Trapnell, B.C.2
Humphries, M.3
Carey, B.4
Calcedo, R.5
Rouhani, F.6
-
97
-
-
28844483864
-
High levels of persistent expression of α1-Antitrypsin mediated by the nonhuman primate serotype rh.10 adeno-associated virus despite preexisting immunity to common human adeno-associated viruses
-
DOI 10.1016/j.ymthe.2005.09.003, PII S1525001605015911
-
De BP, Heguy A, Hackett NR, Ferris B, Leopold PL, Lee J, et al. High levels of persistent expression of alpha1-antitrypsin mediated by the nonhuman primate serotype rh.10 adeno-associated virus despite preexisting immunity to common human adeno-associated viruses. Mol Ther. 2006;13(1):67-76. (Pubitemid 41763484)
-
(2006)
Molecular Therapy
, vol.13
, Issue.1
, pp. 67-76
-
-
De, B.P.1
Heguy, A.2
Hackett, N.R.3
Ferris, B.4
Leopold, P.L.5
Lee, J.6
Pierre, L.7
Gao, G.8
Wilson, J.M.9
Crystal, R.G.10
-
98
-
-
36148973187
-
1-AT-deficient monocytes
-
DOI 10.1089/hum.2007.073
-
McNab GL, Ahmad A, Mistry D, Stockley RA. Modification of gene expression and increase in alpha1-antitrypsin (alpha1-AT) secretion after homologous recombination in alpha1-AT-deficient monocytes. Hum Gene Ther. 2007;18(11):1171-7. (Pubitemid 350114689)
-
(2007)
Human Gene Therapy
, vol.18
, Issue.11
, pp. 1171-1177
-
-
McNab, G.L.1
Ahmad, A.2
Mistry, D.3
Stockley, R.A.4
-
99
-
-
84862705104
-
A novel model and molecular therapy for Z alpha-1 antitrypsin deficiency
-
22076419 1:CAS:528:DC%2BC38XjvFKktLY%3D 10.1007/s00335-011-9370-2
-
McNab GL, Dafforn TR, Wood A, Sapey E, Stockley RA. A novel model and molecular therapy for Z alpha-1 antitrypsin deficiency. Mamm Genome. 2012;23(3-4):241-9.
-
(2012)
Mamm Genome
, vol.23
, Issue.3-4
, pp. 241-249
-
-
McNab, G.L.1
Dafforn, T.R.2
Wood, A.3
Sapey, E.4
Stockley, R.A.5
-
100
-
-
48649084090
-
Sustained expression of alpha1-antitrypsin after transplantation of manipulated hematopoietic stem cells
-
18323534 1:CAS:528:DC%2BD1cXpsFOntrc%3D 10.1165/rcmb.2007-0133OC
-
Wilson AA, Kwok LW, Hovav AH, Ohle SJ, Little FF, Fine A, et al. Sustained expression of alpha1-antitrypsin after transplantation of manipulated hematopoietic stem cells. Am J Respir Cell Mol Biol. 2008;39(2):133-41.
-
(2008)
Am J Respir Cell Mol Biol
, vol.39
, Issue.2
, pp. 133-141
-
-
Wilson, A.A.1
Kwok, L.W.2
Hovav, A.H.3
Ohle, S.J.4
Little, F.F.5
Fine, A.6
-
101
-
-
77955272990
-
Establishment of lentiviral-vector-mediated model of human alpha-1 antitrypsin delivery into hepatocyte-like cells differentiated from mesenchymal stem cells
-
20434188 1:CAS:528:DC%2BC3cXntVOrsrg%3D 10.1016/j.tice.2010.03.007
-
Ghaedi M, Lotfi AS, Soleimani M. Establishment of lentiviral-vector- mediated model of human alpha-1 antitrypsin delivery into hepatocyte-like cells differentiated from mesenchymal stem cells. Tissue Cell. 2010;42(3):181-9.
-
(2010)
Tissue Cell
, vol.42
, Issue.3
, pp. 181-189
-
-
Ghaedi, M.1
Lotfi, A.S.2
Soleimani, M.3
-
102
-
-
79954910852
-
Adipose tissue-derived mesenchymal stem cell-based liver gene delivery
-
21168381 1:CAS:528:DC%2BC3MXkvFGhu7o%3D 10.1016/j.jhep.2010.07.051
-
Li H, Zhang B, Lu Y, Jorgensen M, Petersen B, Song S. Adipose tissue-derived mesenchymal stem cell-based liver gene delivery. J Hepatol. 2011;54(5):930-8.
-
(2011)
J Hepatol
, vol.54
, Issue.5
, pp. 930-938
-
-
Li, H.1
Zhang, B.2
Lu, Y.3
Jorgensen, M.4
Petersen, B.5
Song, S.6
-
103
-
-
77955176432
-
Ex vivo transduction and transplantation of bone marrow cells for liver gene delivery of alpha1-antitrypsin
-
20551917 1:CAS:528:DC%2BC3cXntlOht7g%3D 10.1038/mt.2010.116
-
Li H, Lu Y, Witek RP, Chang LJ, Campbell-Thompson M, Jorgensen M, et al. Ex vivo transduction and transplantation of bone marrow cells for liver gene delivery of alpha1-antitrypsin. Mol Ther. 2010;18(8):1553-8.
-
(2010)
Mol Ther
, vol.18
, Issue.8
, pp. 1553-1558
-
-
Li, H.1
Lu, Y.2
Witek, R.P.3
Chang, L.J.4
Campbell-Thompson, M.5
Jorgensen, M.6
-
104
-
-
80054987997
-
Targeted gene correction of alpha1-antitrypsin deficiency in induced pluripotent stem cells
-
21993621 1:CAS:528:DC%2BC3MXhtlSkur7P 10.1038/nature10424
-
Yusa K, Rashid ST, Strick-Marchand H, Varela I, Liu PQ, Paschon DE, et al. Targeted gene correction of alpha1-antitrypsin deficiency in induced pluripotent stem cells. Nature. 2011;478(7369):391-4.
-
(2011)
Nature
, vol.478
, Issue.7369
, pp. 391-394
-
-
Yusa, K.1
Rashid, S.T.2
Strick-Marchand, H.3
Varela, I.4
Liu, P.Q.5
Paschon, D.E.6
-
105
-
-
79960617712
-
The fibrinogen cleavage product Aalpha-Val360, a specific marker of neutrophil elastase activity in vivo
-
21617168 10.1136/thx.2010.154690
-
Carter RI, Mumford RA, Treonze KM, Finke PE, Davies P, Si Q, et al. The fibrinogen cleavage product Aalpha-Val360, a specific marker of neutrophil elastase activity in vivo. Thorax. 2011;66(8):686-91.
-
(2011)
Thorax
, vol.66
, Issue.8
, pp. 686-691
-
-
Carter, R.I.1
Mumford, R.A.2
Treonze, K.M.3
Finke, P.E.4
Davies, P.5
Si, Q.6
-
106
-
-
0025775006
-
Purification and biochemical characterization of recombinant alpha 1-antitrypsin variants expressed in Escherichia coli
-
2012806 1:CAS:528:DyaK3MXhsF2lsL0%3D 10.1021/bi00228a017
-
Bischoff R, Speck D, Lepage P, Delatre L, Ledoux C, Brown SW, et al. Purification and biochemical characterization of recombinant alpha 1-antitrypsin variants expressed in Escherichia coli. Biochemistry. 1991;30(14):3464-72.
-
(1991)
Biochemistry
, vol.30
, Issue.14
, pp. 3464-3472
-
-
Bischoff, R.1
Speck, D.2
Lepage, P.3
Delatre, L.4
Ledoux, C.5
Brown, S.W.6
-
107
-
-
0032439236
-
Protein engineering of chimeric Serpins: An investigation into effects of the serpin scaffold and reactive centre loop length
-
Bottomley SP, Stone SR. Protein engineering of chimeric Serpins: an investigation into effects of the serpin scaffold and reactive centre loop length. Protein Eng. 1998;11(12):1243-7. (Pubitemid 29012135)
-
(1998)
Protein Engineering
, vol.11
, Issue.12
, pp. 1243-1247
-
-
Bottomley, S.P.1
Stone, S.R.2
-
108
-
-
0010730762
-
1- antitrypsin in Escherichia coli
-
Courtney M, Buchwalder A, Tessier LH, Jaye M, Benavente A, Balland A, et al. High-level production of biologically active human alpha 1-antitrypsin in Escherichia coli. Proc Natl Acad Sci USA. 1984;81(3):669-73. (Pubitemid 14199007)
-
(1984)
Proceedings of the National Academy of Sciences of the United States of America
, vol.81
, Issue.3
, pp. 669-673
-
-
Courtney, M.1
Buchwalder, A.2
Tessier, L.H.3
-
109
-
-
34547615819
-
Recombinant human alpha 1 proteinase inhibitor: Glycosylation, stability and biological activity
-
Washington DC
-
Karnaukhova E, Ophir Y, Golding B, Shrake A, editors. Recombinant human alpha 1 proteinase inhibitor: glycosylation, stability and biological activity. 10th FDA Science Forum: the critical path from concept to consumer, Washington DC; 2004.
-
(2004)
10th FDA Science Forum: The Critical Path from Concept to Consumer
-
-
Karnaukhova, E.1
Ophir, Y.2
Golding, B.3
Shrake, A.4
-
110
-
-
0023588232
-
Augmentation of lung antineutrophil elastase capacity with recombinant human α-1-antitrypsin
-
Casolaro MA, Fells G, Wewers M, Pierce JE, Ogushi F, Hubbard R, et al. Augmentation of lung antineutrophil elastase capacity with recombinant human alpha-1-antitrypsin. J Appl Physiol. 1987;63(5):2015-23. (Pubitemid 18016433)
-
(1987)
Journal of Applied Physiology
, vol.63
, Issue.5
, pp. 2015-2023
-
-
Casolaro, M.A.1
Fells, G.2
Wewers, M.3
Pierce, J.E.4
Ogushi, F.5
Hubbard, R.6
Sellers, S.7
Forstrom, J.8
Lyons, D.9
Kawasaki, G.10
Crystal, R.G.11
-
111
-
-
0028973156
-
Purification and characterization of alpha 1-antitrypsin secreted by recombinant yeast Saccharomyces diastaticus
-
7576538 1:CAS:528:DyaK2MXos1Gns7k%3D 10.1016/0168-1656(95)00079-6
-
Kwon KS, Song M, Yu MH. Purification and characterization of alpha 1-antitrypsin secreted by recombinant yeast Saccharomyces diastaticus. J Biotechnol. 1995;42(3):191-5.
-
(1995)
J Biotechnol
, vol.42
, Issue.3
, pp. 191-195
-
-
Kwon, K.S.1
Song, M.2
Yu, M.H.3
-
112
-
-
0035814361
-
1-antitrypsin
-
DOI 10.1016/S0141-0229(01)00444-6, PII S0141022901004446
-
Tamer IM, Chisti Y. Production and recovery of recombinant protease inhibitor alpha 1 antitrypsin. Enzyme Microb Technol. 2001;29:611-20. (Pubitemid 33132169)
-
(2001)
Enzyme and Microbial Technology
, vol.29
, Issue.10
, pp. 611-620
-
-
Tamer, I.M.1
Chisti, Y.2
-
113
-
-
0033678797
-
Effects of sugar concentration on recombinant human alpha(1)-antitrypsin production by genetically engineered rice cell
-
11080650 1:CAS:528:DC%2BD3cXoslGlt78%3D 10.1016/S1369-703X(00)00088-7
-
Terashima M, Ejiri Y, Hashikawa N, Yoshida H. Effects of sugar concentration on recombinant human alpha(1)-antitrypsin production by genetically engineered rice cell. Biochem Eng J. 2000;6(3):201-5.
-
(2000)
Biochem Eng J
, vol.6
, Issue.3
, pp. 201-205
-
-
Terashima, M.1
Ejiri, Y.2
Hashikawa, N.3
Yoshida, H.4
-
114
-
-
0035121741
-
Expression and purification of functional human α-1-antitrypsin from cultured plant cells
-
DOI 10.1021/bp0001516
-
Huang J, Sutliff TD, Wu L, Nandi S, Benge K, Terashima M, et al. Expression and purification of functional human alpha-1-Antitrypsin from cultured plant cells. Biotechnol Prog. 2001;17(1):126-33. (Pubitemid 32145384)
-
(2001)
Biotechnology Progress
, vol.17
, Issue.1
, pp. 126-133
-
-
Huang, J.1
Sutliff, T.D.2
Wu, L.3
Nandi, S.4
Benge, K.5
Terashima, M.6
Ralston, A.H.7
Drohan, W.8
Huang, N.9
Rodriguez, R.L.10
|